| Internal Medicine | Lifetime | 54 | GB 4 | 98.94 |
| Critical Care and Intensive Care Medicine | Lifetime | 89 | GB 5 | 98.27 |
| Hematology | Lifetime | 300 | GB 21 | 98.23 |
| Rheumatology | Lifetime | 485 | GB 47 | 97.89 |
| Medical Biochemistry | Lifetime | 462 | GB 27 | 86.29 |
| Internal Medicine | 2021-2025 | 21 | GB 2 | 97.61 |
| Surgery | 2021-2025 | 641 | GB 40 | 94.44 |
| Hematology | 2021-2025 | 229 | GB 17 | 91.03 |
| Critical Care and Intensive Care Medicine | 2021-2025 | 146 | GB 15 | 83.23 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 957 | GB 63 | 79.09 |
| Rheumatology | 2021-2025 | 470 | GB 36 | 75.43 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 93 | GB 7 | 99.67 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 32 | GB 6 | 99.41 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 84 | GB 7 | 99.09 |
| Blood transfusion and management | Lifetime | 45 | GB 4 | 98.74 |
| Systemic Lupus Erythematosus Research | Lifetime | 257 | GB 27 | 99.12 |
| COVID-19 Clinical Research Studies | Lifetime | 441 | GB 48 | 98.25 |
| Platelet Disorders and Treatments | Lifetime | 221 | GB 20 | 98.50 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 65 | GB 5 | 98.19 |
| Blood groups and transfusion | Lifetime | 381 | GB 44 | 97.45 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 887 | GB 41 | 98.00 |
| Blood disorders and treatments | Lifetime | 332 | GB 28 | 96.24 |
| Trauma and Emergency Care Studies | Lifetime | 646 | GB 39 | 97.01 |
| Complement system in diseases | Lifetime | 439 | GB 50 | 96.25 |
| Renal Diseases and Glomerulopathies | Lifetime | 830 | GB 54 | 96.46 |
| Hemostasis and retained surgical items | Lifetime | 117 | GB 9 | 94.84 |
| Diagnosis and Treatment of Venous Diseases | Lifetime | 493 | GB 74 | 94.15 |
| Intramuscular injections and effects | Lifetime | 193 | GB 18 | 86.20 |
| Case Reports on Hematomas | Lifetime | 908 | GB 47 | 67.55 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 53 | GB 2 | 99.19 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 25 | GB 1 | 97.34 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 22 | GB 4 | 96.22 |
| Platelet Disorders and Treatments | 2021-2025 | 120 | GB 14 | 95.87 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 742 | GB 38 | 95.03 |
| Intramuscular injections and effects | 2021-2025 | 13 | GB 4 | 92.96 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | 2021-2025 | 143 | GB 17 | 91.72 |
| Diagnosis and Treatment of Venous Diseases | 2021-2025 | 388 | GB 37 | 80.75 |
| Blood transfusion and management | 2021-2025 | 390 | GB 27 | 76.16 |
| Hemophilia Treatment and Research | 2021-2025 | 698 | GB 50 | 70.80 |
| Hemostasis and retained surgical items | 2021-2025 | 573 | GB 4 | 44.24 |
